SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (25718)9/23/1998 4:26:00 PM
From: aknahow  Read Replies (1) of 32384
 
Nice point. Think I remember that Bayer also paid more than twice what Chiron paid for its' diagnostic unit, and way above what the market was valuing it at as part of Chirons stock market capitalization. While the deal itself is obviously of interest I think the implications are also important.

I certainaly did not see Bayer doing either deal but I would like to hear from anyone that did or who could provide insights into the type of companies Hoechst, BASF, DuPont or Merck might consider targets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News